hepatitis B

News

GSK eyes October FDA verdict on chronic hep B drug

GSK's antisense-based drug for chronic hepatitis B (CHB), bepirovirsen, has started a speedy FDA review that should deliver a verdict by 26th October.

News

GSK preps filings for chronic hepatitis B drug bepirovirsen

GSK will file its chronic hepatitis B virus therapy bepirovirsen for approval in the first quarter, after it hit the mark in two phase 3 trials.

News

Acting CDC director and former tech investor Jim O'Neill

CDC signs off on advice ending universal hepatitis B jabs

Overturning decades of advice, the CDC has said it no longer recommends that all US newborns receive a hepatitis B vaccine.

News

CDC panel votes to scrap hepatitis B birth dose advice

CDC advisers vote to overturn decades of US policy and abandon endorsement of universal hepatitis B vaccination for newborns in the US.

Patients

circle of people paper cutouts in different colours in the palms of a paerson's hands

Why inclusive engagement is key to closing health gaps

Over the summer, the People Centric Advocacy Model (PCAM) launched, a new approach to tackling health inequalities.

News

ACIP pushes back vote on hepatitis B vaccine

ACIP has agreed to push back a vote on recommendations for a birth dose of hepatitis B vaccine, as panellists were unhappy with the proposed wording.

GSK eyes October FDA verdict on chronic hep B drug

GSK preps filings for chronic hepatitis B drug bepirovirsen

CDC signs off on advice ending universal hepatitis B jabs

CDC panel votes to scrap hepatitis B birth dose advice

Why inclusive engagement is key to closing health gaps

ACIP pushes back vote on hepatitis B vaccine

Chiesi signs $1.9bn deal to buy KalVista and its HAE drug

Using AI-driven synthetic personas to take your insights fur...

hepatitis B

Editor's Picks